nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—hematopoietic system—hematologic cancer	0.0465	0.446	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—blood—hematologic cancer	0.0308	0.295	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—lung—hematologic cancer	0.027	0.259	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—Disease—HDAC9—hematologic cancer	0.000879	0.0033	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—H3F3B—hematologic cancer	0.00087	0.00327	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	0.000843	0.00317	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ARNTL—hematologic cancer	0.000841	0.00316	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NPM1—hematologic cancer	0.000838	0.00315	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ACP5—hematologic cancer	0.000818	0.00307	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CA9—hematologic cancer	0.000818	0.00307	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NCOR2—hematologic cancer	0.000807	0.00303	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FGF19—hematologic cancer	0.000803	0.00301	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—RPS14—hematologic cancer	0.000796	0.00299	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—DKK1—hematologic cancer	0.00079	0.00296	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL17—hematologic cancer	0.000789	0.00296	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AGRN—hematologic cancer	0.000789	0.00296	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—STAT5B—hematologic cancer	0.000784	0.00294	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NUP98—hematologic cancer	0.000784	0.00294	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Irinotecan—hematologic cancer	0.000778	0.00124	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Mitoxantrone—hematologic cancer	0.000778	0.00124	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Vinblastine—hematologic cancer	0.000776	0.00123	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Epirubicin—hematologic cancer	0.000776	0.00123	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCR5—hematologic cancer	0.000774	0.00291	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.000773	0.00123	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Irinotecan—hematologic cancer	0.000772	0.00123	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Mitoxantrone—hematologic cancer	0.000772	0.00123	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Ifosfamide—hematologic cancer	0.000771	0.00123	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—IDH1—hematologic cancer	0.000769	0.00289	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Lenalidomide—hematologic cancer	0.000768	0.00122	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CST3—hematologic cancer	0.000766	0.00288	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Lenalidomide—hematologic cancer	0.000762	0.00121	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Carmustine—hematologic cancer	0.000761	0.00121	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Lenalidomide—hematologic cancer	0.000761	0.00121	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Bortezomib—hematologic cancer	0.000761	0.00121	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ADCY7—hematologic cancer	0.000761	0.00286	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LEF1—hematologic cancer	0.000761	0.00286	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCC3—hematologic cancer	0.00076	0.00285	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TXN—hematologic cancer	0.00076	0.00285	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTO1—hematologic cancer	0.00076	0.00285	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Gemcitabine—hematologic cancer	0.000758	0.00121	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Hydroxyurea—hematologic cancer	0.000758	0.0012	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Lenalidomide—hematologic cancer	0.000757	0.0012	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—NUP214—hematologic cancer	0.000755	0.00284	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Alitretinoin—hematologic cancer	0.000754	0.0012	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.000753	0.0012	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Methotrexate—hematologic cancer	0.000752	0.0012	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Gemcitabine—hematologic cancer	0.000752	0.0012	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Vincristine—hematologic cancer	0.000752	0.00119	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Hydroxyurea—hematologic cancer	0.000751	0.00119	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Hydroxyurea—hematologic cancer	0.000751	0.00119	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GNA13—hematologic cancer	0.000748	0.00281	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Hydroxyurea—hematologic cancer	0.000746	0.00119	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Ifosfamide—hematologic cancer	0.000746	0.00118	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SPHK1—hematologic cancer	0.000744	0.00279	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Thiotepa—hematologic cancer	0.000744	0.00118	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Vinorelbine—hematologic cancer	0.000743	0.00118	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—XIAP—hematologic cancer	0.00074	0.00278	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MTR—hematologic cancer	0.00074	0.00278	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Melphalan—hematologic cancer	0.000738	0.00117	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TIAM1—hematologic cancer	0.000736	0.00276	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Bortezomib—hematologic cancer	0.000735	0.00117	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Mitoxantrone—hematologic cancer	0.000732	0.00116	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Irinotecan—hematologic cancer	0.000732	0.00116	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Vincristine—hematologic cancer	0.000727	0.00116	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ENO2—hematologic cancer	0.000726	0.00272	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SMARCA4—hematologic cancer	0.000721	0.00271	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Thalidomide—hematologic cancer	0.00072	0.00114	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Vinorelbine—hematologic cancer	0.000718	0.00114	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Doxorubicin—hematologic cancer	0.000718	0.00114	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Lenalidomide—hematologic cancer	0.000718	0.00114	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—UGT1A1—hematologic cancer	0.000715	0.00268	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—JAK3—hematologic cancer	0.000713	0.00268	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Thiotepa—hematologic cancer	0.00071	0.00113	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Mitoxantrone—hematologic cancer	0.000708	0.00113	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Irinotecan—hematologic cancer	0.000708	0.00113	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Hydroxyurea—hematologic cancer	0.000708	0.00112	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Bortezomib—hematologic cancer	0.000707	0.00112	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Cisplatin—hematologic cancer	0.000707	0.00112	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.000702	0.00112	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Bleomycin—hematologic cancer	0.000702	0.00112	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Bortezomib—hematologic cancer	0.000701	0.00111	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Bortezomib—hematologic cancer	0.000701	0.00111	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Bortezomib—hematologic cancer	0.000697	0.00111	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Bleomycin—hematologic cancer	0.000696	0.00111	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CRABP1—hematologic cancer	0.000695	0.00261	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC22A1—hematologic cancer	0.000695	0.00261	CbGpPWpGaD
Glycerol Phenylbutyrate—Dermatitis—Bleomycin—hematologic cancer	0.000695	0.0011	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Carmustine—hematologic cancer	0.000691	0.0011	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Vinorelbine—hematologic cancer	0.00069	0.0011	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—SDC1—hematologic cancer	0.000688	0.00258	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Thalidomide—hematologic cancer	0.000686	0.00109	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Thiotepa—hematologic cancer	0.000686	0.00109	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Alitretinoin—hematologic cancer	0.000685	0.00109	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Vinorelbine—hematologic cancer	0.000685	0.00109	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Vinorelbine—hematologic cancer	0.000684	0.00109	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL13—hematologic cancer	0.000684	0.00257	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCR7—hematologic cancer	0.000684	0.00257	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Vinorelbine—hematologic cancer	0.00068	0.00108	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALOX5—hematologic cancer	0.000678	0.00254	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Ifosfamide—hematologic cancer	0.000677	0.00108	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NCOR2—hematologic cancer	0.000675	0.00253	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL3RA—hematologic cancer	0.000666	0.0025	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CRKL—hematologic cancer	0.000666	0.0025	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—LCK—hematologic cancer	0.000666	0.0025	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Thalidomide—hematologic cancer	0.000663	0.00105	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Bortezomib—hematologic cancer	0.000661	0.00105	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Vincristine—hematologic cancer	0.00066	0.00105	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Thiotepa—hematologic cancer	0.000659	0.00105	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Carmustine—hematologic cancer	0.000659	0.00105	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NUP98—hematologic cancer	0.000656	0.00246	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Bleomycin—hematologic cancer	0.000655	0.00104	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Prednisone—hematologic cancer	0.000654	0.00104	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Thiotepa—hematologic cancer	0.000654	0.00104	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Thiotepa—hematologic cancer	0.000653	0.00104	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—H3F3A—hematologic cancer	0.000653	0.00245	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Alitretinoin—hematologic cancer	0.000653	0.00104	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Thiotepa—hematologic cancer	0.00065	0.00103	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Etoposide—hematologic cancer	0.000648	0.00103	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Ifosfamide—hematologic cancer	0.000645	0.00103	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Vinorelbine—hematologic cancer	0.000645	0.00102	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000643	0.00102	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RGS2—hematologic cancer	0.000643	0.00241	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Mitoxantrone—hematologic cancer	0.000643	0.00102	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Irinotecan—hematologic cancer	0.000643	0.00102	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Etoposide—hematologic cancer	0.000642	0.00102	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Thalidomide—hematologic cancer	0.000638	0.00101	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NCOA3—hematologic cancer	0.000637	0.00239	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ADCY7—hematologic cancer	0.000637	0.00239	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Carmustine—hematologic cancer	0.000637	0.00101	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TRH—hematologic cancer	0.000636	0.00239	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TRIO—hematologic cancer	0.000636	0.00239	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CMA1—hematologic cancer	0.000636	0.00239	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PRKCZ—hematologic cancer	0.000635	0.00238	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NUP214—hematologic cancer	0.000633	0.00237	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Thalidomide—hematologic cancer	0.000632	0.001	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Thalidomide—hematologic cancer	0.000632	0.001	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Alitretinoin—hematologic cancer	0.000631	0.001	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Vincristine—hematologic cancer	0.000629	0.001	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Thalidomide—hematologic cancer	0.000628	0.000999	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	0.000626	0.00235	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Gemcitabine—hematologic cancer	0.000626	0.000995	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CALR—hematologic cancer	0.000624	0.00234	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Ifosfamide—hematologic cancer	0.000624	0.000991	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AGO2—hematologic cancer	0.000622	0.00234	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SPHK1—hematologic cancer	0.000622	0.00234	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MTR—hematologic cancer	0.00062	0.00233	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCG2—hematologic cancer	0.00062	0.00233	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Thiotepa—hematologic cancer	0.000616	0.000979	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HDAC9—hematologic cancer	0.000616	0.00231	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LPAR1—hematologic cancer	0.000616	0.00231	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PARP1—hematologic cancer	0.000613	0.0023	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Mitoxantrone—hematologic cancer	0.000613	0.000974	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Irinotecan—hematologic cancer	0.000613	0.000974	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Carmustine—hematologic cancer	0.000612	0.000973	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—H3F3B—hematologic cancer	0.00061	0.00229	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Etoposide—hematologic cancer	0.000609	0.000968	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Vincristine—hematologic cancer	0.000608	0.000966	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ENO2—hematologic cancer	0.000608	0.00228	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Carmustine—hematologic cancer	0.000607	0.000965	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Carmustine—hematologic cancer	0.000607	0.000964	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Alitretinoin—hematologic cancer	0.000607	0.000964	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Carmustine—hematologic cancer	0.000603	0.000959	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—FBXW7—hematologic cancer	0.000603	0.00226	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Alitretinoin—hematologic cancer	0.000602	0.000956	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Dexamethasone—hematologic cancer	0.000601	0.000955	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Betamethasone—hematologic cancer	0.000601	0.000955	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Alitretinoin—hematologic cancer	0.000601	0.000955	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Ifosfamide—hematologic cancer	0.0006	0.000953	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Alitretinoin—hematologic cancer	0.000598	0.00095	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Gemcitabine—hematologic cancer	0.000597	0.000948	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Thalidomide—hematologic cancer	0.000596	0.000947	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Triamcinolone—hematologic cancer	0.000595	0.000945	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Ifosfamide—hematologic cancer	0.000595	0.000945	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Ifosfamide—hematologic cancer	0.000594	0.000944	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Irinotecan—hematologic cancer	0.000592	0.000941	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CXCR4—hematologic cancer	0.000592	0.00222	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HDAC2—hematologic cancer	0.000592	0.00222	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTT1—hematologic cancer	0.00059	0.00221	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Etoposide—hematologic cancer	0.000589	0.000936	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CD44—hematologic cancer	0.000585	0.0022	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Vincristine—hematologic cancer	0.000585	0.000929	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Cisplatin—hematologic cancer	0.000583	0.000927	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Triamcinolone—hematologic cancer	0.000582	0.000926	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	0.000581	0.00218	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Vincristine—hematologic cancer	0.00058	0.000921	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Vincristine—hematologic cancer	0.000579	0.000921	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CBL—hematologic cancer	0.000577	0.00216	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SDC1—hematologic cancer	0.000576	0.00216	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Vincristine—hematologic cancer	0.000576	0.000915	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Carmustine—hematologic cancer	0.000572	0.000909	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Mitoxantrone—hematologic cancer	0.000569	0.000905	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Irinotecan—hematologic cancer	0.000569	0.000905	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Alitretinoin—hematologic cancer	0.000567	0.000901	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CNR2—hematologic cancer	0.000567	0.00213	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PDE4B—hematologic cancer	0.000567	0.00213	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Irinotecan—hematologic cancer	0.000565	0.000897	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Mitoxantrone—hematologic cancer	0.000565	0.000897	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Mitoxantrone—hematologic cancer	0.000564	0.000896	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Irinotecan—hematologic cancer	0.000564	0.000896	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGF19—hematologic cancer	0.000562	0.00211	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Irinotecan—hematologic cancer	0.000561	0.000892	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Mitoxantrone—hematologic cancer	0.000561	0.000892	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Ifosfamide—hematologic cancer	0.00056	0.00089	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RAC2—hematologic cancer	0.000557	0.00209	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Cisplatin—hematologic cancer	0.000556	0.000884	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Gemcitabine—hematologic cancer	0.000555	0.000881	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—DKK1—hematologic cancer	0.000553	0.00208	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	0.00055	0.00207	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HSP90AA1—hematologic cancer	0.00055	0.00206	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Gemcitabine—hematologic cancer	0.00055	0.000874	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Gemcitabine—hematologic cancer	0.000549	0.000873	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STAT5B—hematologic cancer	0.000549	0.00206	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Methotrexate—hematologic cancer	0.000547	0.000869	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Gemcitabine—hematologic cancer	0.000546	0.000868	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Vincristine—hematologic cancer	0.000546	0.000868	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	0.000543	0.00204	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Betamethasone—hematologic cancer	0.00054	0.000858	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Dexamethasone—hematologic cancer	0.00054	0.000858	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Etoposide—hematologic cancer	0.000534	0.000849	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Betamethasone—hematologic cancer	0.000533	0.000847	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Dexamethasone—hematologic cancer	0.000533	0.000847	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADCY7—hematologic cancer	0.000533	0.002	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Mitoxantrone—hematologic cancer	0.000532	0.000845	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Irinotecan—hematologic cancer	0.000532	0.000845	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—STAT1—hematologic cancer	0.00053	0.00199	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000529	0.000841	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000529	0.000841	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Betamethasone—hematologic cancer	0.000529	0.00084	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Dexamethasone—hematologic cancer	0.000529	0.00084	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Prednisone—hematologic cancer	0.000524	0.000832	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	0.00052	0.00195	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—XIAP—hematologic cancer	0.000518	0.00195	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Gemcitabine—hematologic cancer	0.000518	0.000823	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Cisplatin—hematologic cancer	0.000517	0.000822	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Cisplatin—hematologic cancer	0.000513	0.000815	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Cisplatin—hematologic cancer	0.000512	0.000814	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Epirubicin—hematologic cancer	0.000512	0.000813	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Etoposide—hematologic cancer	0.00051	0.00081	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SH2B3—hematologic cancer	0.000505	0.0019	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SMARCA4—hematologic cancer	0.000505	0.0019	CbGpPWpGaD
Glycerol Phenylbutyrate—Flatulence—Epirubicin—hematologic cancer	0.000504	0.000801	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GZMB—hematologic cancer	0.000502	0.00188	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000501	0.000797	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000501	0.000797	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—GRB2—hematologic cancer	0.000496	0.00186	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PDGFA—hematologic cancer	0.000495	0.00186	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Etoposide—hematologic cancer	0.000493	0.000783	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CTNNA1—hematologic cancer	0.00049	0.00184	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NQO1—hematologic cancer	0.00049	0.00184	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CD44—hematologic cancer	0.00049	0.00184	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—KITLG—hematologic cancer	0.000488	0.00183	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HSPB1—hematologic cancer	0.000487	0.00183	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EIF4EBP1—hematologic cancer	0.000487	0.00183	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL3—hematologic cancer	0.000487	0.00183	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Prednisolone—hematologic cancer	0.000486	0.000772	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Triamcinolone—hematologic cancer	0.000485	0.00077	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Dexamethasone—hematologic cancer	0.000485	0.00077	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Betamethasone—hematologic cancer	0.000485	0.00077	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Cisplatin—hematologic cancer	0.000483	0.000768	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SDC1—hematologic cancer	0.000482	0.00181	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTHLH—hematologic cancer	0.000482	0.00181	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	0.00048	0.0018	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—STAT5A—hematologic cancer	0.000477	0.00179	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Etoposide—hematologic cancer	0.000474	0.000753	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Doxorubicin—hematologic cancer	0.000473	0.000752	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN2B—hematologic cancer	0.000473	0.00177	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Prednisone—hematologic cancer	0.00047	0.000747	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Etoposide—hematologic cancer	0.00047	0.000746	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Etoposide—hematologic cancer	0.000469	0.000746	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTGER4—hematologic cancer	0.000469	0.00176	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LCK—hematologic cancer	0.000467	0.00175	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Etoposide—hematologic cancer	0.000467	0.000742	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Doxorubicin—hematologic cancer	0.000466	0.000741	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Prednisone—hematologic cancer	0.000464	0.000738	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYCS—hematologic cancer	0.000464	0.00174	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Prednisolone—hematologic cancer	0.000463	0.000736	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Prednisolone—hematologic cancer	0.000463	0.000735	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HSP90AA1—hematologic cancer	0.000461	0.00173	CbGpPWpGaD
Glycerol Phenylbutyrate—Fatigue—Prednisone—hematologic cancer	0.00046	0.000731	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Prednisolone—hematologic cancer	0.00046	0.000731	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—H3F3A—hematologic cancer	0.000457	0.00172	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CD86—hematologic cancer	0.000457	0.00172	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HES1—hematologic cancer	0.000451	0.00169	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NCOR1—hematologic cancer	0.000448	0.00168	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Triamcinolone—hematologic cancer	0.000447	0.00071	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRKCZ—hematologic cancer	0.000445	0.00167	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FGF1—hematologic cancer	0.000443	0.00166	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Etoposide—hematologic cancer	0.000442	0.000703	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Betamethasone—hematologic cancer	0.00044	0.000699	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Dexamethasone—hematologic cancer	0.00044	0.000699	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Methotrexate—hematologic cancer	0.000438	0.000695	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—FOXO1—hematologic cancer	0.000437	0.00164	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Prednisone—hematologic cancer	0.000437	0.000694	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Prednisolone—hematologic cancer	0.000436	0.000694	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PDGFRB—hematologic cancer	0.000436	0.00164	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Triamcinolone—hematologic cancer	0.00043	0.000683	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PARP1—hematologic cancer	0.000429	0.00161	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PDGFRA—hematologic cancer	0.000429	0.00161	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—JAK1—hematologic cancer	0.000428	0.00161	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PRKCG—hematologic cancer	0.000428	0.00161	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Triamcinolone—hematologic cancer	0.000426	0.000677	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Triamcinolone—hematologic cancer	0.000426	0.000676	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Triamcinolone—hematologic cancer	0.000423	0.000673	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FBXW7—hematologic cancer	0.000422	0.00159	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Prednisone—hematologic cancer	0.000422	0.000671	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Betamethasone—hematologic cancer	0.000419	0.000667	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Dexamethasone—hematologic cancer	0.000419	0.000667	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	0.000415	0.00156	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HDAC2—hematologic cancer	0.000414	0.00156	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCR4—hematologic cancer	0.000414	0.00156	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Epirubicin—hematologic cancer	0.000409	0.000651	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTP1—hematologic cancer	0.000409	0.00153	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Betamethasone—hematologic cancer	0.000405	0.000644	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Dexamethasone—hematologic cancer	0.000405	0.000644	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CBL—hematologic cancer	0.000404	0.00152	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Triamcinolone—hematologic cancer	0.000401	0.000638	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL3—hematologic cancer	0.0004	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MTHFR—hematologic cancer	0.000396	0.00149	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	0.000395	0.00148	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TERT—hematologic cancer	0.000395	0.00148	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HLA-A—hematologic cancer	0.000395	0.00148	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTPN1—hematologic cancer	0.000393	0.00147	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Methotrexate—hematologic cancer	0.000393	0.000624	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Dexamethasone—hematologic cancer	0.00039	0.000619	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Betamethasone—hematologic cancer	0.00039	0.000619	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Methotrexate—hematologic cancer	0.000388	0.000616	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCB1—hematologic cancer	0.000387	0.00145	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Betamethasone—hematologic cancer	0.000387	0.000614	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Dexamethasone—hematologic cancer	0.000387	0.000614	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RASGRP1—hematologic cancer	0.000386	0.00145	CbGpPWpGaD
Glycerol Phenylbutyrate—Dermatitis—Betamethasone—hematologic cancer	0.000386	0.000614	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Dexamethasone—hematologic cancer	0.000386	0.000614	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PDGFB—hematologic cancer	0.000386	0.00145	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000385	0.000612	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SYK—hematologic cancer	0.000385	0.00145	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HSP90AA1—hematologic cancer	0.000385	0.00145	CbGpPWpGaD
Glycerol Phenylbutyrate—Fatigue—Methotrexate—hematologic cancer	0.000385	0.000611	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Betamethasone—hematologic cancer	0.000384	0.00061	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Dexamethasone—hematologic cancer	0.000384	0.00061	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Prednisone—hematologic cancer	0.000383	0.000609	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Doxorubicin—hematologic cancer	0.000379	0.000602	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—TSC2—hematologic cancer	0.000377	0.00142	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NCOR1—hematologic cancer	0.000376	0.00141	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTM1—hematologic cancer	0.000376	0.00141	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STAT1—hematologic cancer	0.000371	0.00139	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Epirubicin—hematologic cancer	0.000368	0.000584	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Prednisone—hematologic cancer	0.000365	0.00058	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000365	0.00058	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Dexamethasone—hematologic cancer	0.000364	0.000579	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Betamethasone—hematologic cancer	0.000364	0.000579	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Epirubicin—hematologic cancer	0.000363	0.000577	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—FGFR3—hematologic cancer	0.000363	0.00136	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.00036	0.000573	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Epirubicin—hematologic cancer	0.00036	0.000572	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Prednisone—hematologic cancer	0.000353	0.000561	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Methotrexate—hematologic cancer	0.000353	0.000561	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRB2—hematologic cancer	0.000347	0.0013	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PDGFA—hematologic cancer	0.000347	0.0013	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—BAD—hematologic cancer	0.000344	0.00129	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KITLG—hematologic cancer	0.000342	0.00128	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Epirubicin—hematologic cancer	0.000341	0.000543	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—NOTCH1—hematologic cancer	0.00034	0.00128	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Doxorubicin—hematologic cancer	0.00034	0.00054	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Prednisone—hematologic cancer	0.000339	0.000539	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Prednisone—hematologic cancer	0.000337	0.000535	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Prednisone—hematologic cancer	0.000336	0.000534	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Doxorubicin—hematologic cancer	0.000336	0.000534	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Prednisone—hematologic cancer	0.000334	0.000532	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STAT5A—hematologic cancer	0.000334	0.00125	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CD80—hematologic cancer	0.000334	0.00125	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	0.000334	0.00053	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Doxorubicin—hematologic cancer	0.000333	0.000529	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—KIT—hematologic cancer	0.000333	0.00125	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MTHFR—hematologic cancer	0.000332	0.00125	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN2B—hematologic cancer	0.000331	0.00124	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Epirubicin—hematologic cancer	0.00033	0.000525	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PTPN11—hematologic cancer	0.000327	0.00123	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CD86—hematologic cancer	0.00032	0.0012	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Methotrexate—hematologic cancer	0.00032	0.000509	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Prednisone—hematologic cancer	0.000317	0.000504	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CREB1—hematologic cancer	0.000317	0.00119	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.000316	0.000502	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HES1—hematologic cancer	0.000316	0.00119	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NCOR1—hematologic cancer	0.000314	0.00118	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—BRAF—hematologic cancer	0.000313	0.00117	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CSF2—hematologic cancer	0.00031	0.00117	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGF1—hematologic cancer	0.00031	0.00117	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6R—hematologic cancer	0.000309	0.00116	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CREBBP—hematologic cancer	0.000309	0.00116	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FOXO1—hematologic cancer	0.000306	0.00115	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PDGFRB—hematologic cancer	0.000305	0.00115	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Doxorubicin—hematologic cancer	0.000305	0.000485	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Methotrexate—hematologic cancer	0.000305	0.000485	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PDGFRA—hematologic cancer	0.000301	0.00113	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRKCG—hematologic cancer	0.0003	0.00112	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—JAK1—hematologic cancer	0.0003	0.00112	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Epirubicin—hematologic cancer	0.0003	0.000476	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Methotrexate—hematologic cancer	0.000295	0.000469	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—MAP2K1—hematologic cancer	0.000295	0.00111	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CD—hematologic cancer	0.000293	0.0011	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	0.000292	0.0011	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Epirubicin—hematologic cancer	0.000286	0.000454	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Methotrexate—hematologic cancer	0.000284	0.000451	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Methotrexate—hematologic cancer	0.000281	0.000447	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Methotrexate—hematologic cancer	0.000281	0.000447	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—FGF2—hematologic cancer	0.00028	0.00105	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL2RA—hematologic cancer	0.00028	0.00105	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Methotrexate—hematologic cancer	0.00028	0.000444	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CG—hematologic cancer	0.000279	0.00105	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Doxorubicin—hematologic cancer	0.000277	0.000441	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TERT—hematologic cancer	0.000277	0.00104	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3R1—hematologic cancer	0.000276	0.00104	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Epirubicin—hematologic cancer	0.000276	0.000439	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PDGFB—hematologic cancer	0.00027	0.00101	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—JAK2—hematologic cancer	0.000269	0.00101	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Epirubicin—hematologic cancer	0.000265	0.000422	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Methotrexate—hematologic cancer	0.000265	0.000421	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Doxorubicin—hematologic cancer	0.000264	0.00042	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TSC2—hematologic cancer	0.000264	0.000991	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Epirubicin—hematologic cancer	0.000263	0.000418	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Epirubicin—hematologic cancer	0.000263	0.000418	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—MDM2—hematologic cancer	0.000262	0.000984	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Epirubicin—hematologic cancer	0.000262	0.000416	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CREBBP—hematologic cancer	0.000259	0.000971	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Doxorubicin—hematologic cancer	0.000255	0.000406	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—MTOR—hematologic cancer	0.000255	0.000958	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CB—hematologic cancer	0.000255	0.000958	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CD4—hematologic cancer	0.000255	0.000956	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGFR3—hematologic cancer	0.000254	0.000953	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAPK14—hematologic cancer	0.000251	0.000944	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Epirubicin—hematologic cancer	0.000248	0.000394	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ESR1—hematologic cancer	0.000247	0.000926	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Doxorubicin—hematologic cancer	0.000246	0.00039	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CD—hematologic cancer	0.000245	0.00092	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FN1—hematologic cancer	0.000244	0.000915	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Doxorubicin—hematologic cancer	0.000244	0.000387	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Doxorubicin—hematologic cancer	0.000243	0.000387	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Doxorubicin—hematologic cancer	0.000242	0.000385	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALB—hematologic cancer	0.000242	0.000908	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—BAD—hematologic cancer	0.000241	0.000904	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NFKBIA—hematologic cancer	0.000241	0.000904	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN1B—hematologic cancer	0.000239	0.000899	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOTCH1—hematologic cancer	0.000238	0.000895	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CD80—hematologic cancer	0.000234	0.000877	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KIT—hematologic cancer	0.000233	0.000875	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CG—hematologic cancer	0.000233	0.000875	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3R1—hematologic cancer	0.000231	0.000869	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Doxorubicin—hematologic cancer	0.000229	0.000365	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTPN11—hematologic cancer	0.000229	0.00086	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CREB1—hematologic cancer	0.000222	0.000833	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN1A—hematologic cancer	0.000221	0.000829	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTEN—hematologic cancer	0.00022	0.000828	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—BRAF—hematologic cancer	0.000219	0.000823	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL2—hematologic cancer	0.000217	0.000815	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6R—hematologic cancer	0.000216	0.000813	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CREBBP—hematologic cancer	0.000216	0.000812	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CB—hematologic cancer	0.000214	0.000802	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EP300—hematologic cancer	0.00021	0.000789	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAP2K1—hematologic cancer	0.000206	0.000775	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CD—hematologic cancer	0.000205	0.000769	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SRC—hematologic cancer	0.000204	0.000767	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—STAT3—hematologic cancer	0.000197	0.00074	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NRAS—hematologic cancer	0.000197	0.000738	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGF2—hematologic cancer	0.000196	0.000737	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3R1—hematologic cancer	0.000194	0.000727	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MAPK3—hematologic cancer	0.000188	0.000707	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—JAK2—hematologic cancer	0.000188	0.000706	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTEN—hematologic cancer	0.000185	0.000693	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MDM2—hematologic cancer	0.000184	0.000689	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MYC—hematologic cancer	0.000183	0.000688	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TGFB1—hematologic cancer	0.000183	0.000686	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MTOR—hematologic cancer	0.000179	0.000671	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CB—hematologic cancer	0.000179	0.000671	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—EP300—hematologic cancer	0.000176	0.000661	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—KRAS—hematologic cancer	0.000169	0.000635	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN1B—hematologic cancer	0.000168	0.000629	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CASP3—hematologic cancer	0.000164	0.000617	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL2—hematologic cancer	0.000164	0.000616	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCND1—hematologic cancer	0.00016	0.0006	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—JUN—hematologic cancer	0.00016	0.000599	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CA—hematologic cancer	0.000156	0.000584	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN1A—hematologic cancer	0.000155	0.000581	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTEN—hematologic cancer	0.000154	0.00058	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAPK8—hematologic cancer	0.000151	0.000567	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EP300—hematologic cancer	0.000147	0.000553	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HRAS—hematologic cancer	0.000144	0.00054	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SRC—hematologic cancer	0.000143	0.000537	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFA—hematologic cancer	0.000139	0.000523	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STAT3—hematologic cancer	0.000138	0.000518	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NRAS—hematologic cancer	0.000138	0.000517	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6—hematologic cancer	0.000138	0.000517	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAPK3—hematologic cancer	0.000132	0.000495	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CA—hematologic cancer	0.00013	0.000489	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MYC—hematologic cancer	0.000128	0.000482	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TGFB1—hematologic cancer	0.000128	0.00048	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT1—hematologic cancer	0.000127	0.000477	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KRAS—hematologic cancer	0.000119	0.000445	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CA—hematologic cancer	0.000109	0.000409	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKT1—hematologic cancer	0.000106	0.000399	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TP53—hematologic cancer	0.000105	0.000396	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HRAS—hematologic cancer	0.000101	0.000378	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6—hematologic cancer	9.64e-05	0.000362	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT1—hematologic cancer	8.9e-05	0.000334	CbGpPWpGaD
